Ir-titanate nanobiocatalyst and preparation method and application thereof
By using iridium-strontium titanate nanobiocatalyst (Ir-STO) to mimic enzyme activity under acidic and neutral conditions, the problem of imbalance and limited efficacy in the treatment of caries and periodontitis in existing technologies has been solved, achieving highly efficient antibacterial, anti-inflammatory and tissue repair effects.
Patent Information
- Application Number
- CN202511874772.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2025-12-12
- Publication Date
- 2026-04-14
- Estimated Expiration
- 2045-12-12
AI Technical Summary
Existing antibiotics for treating dental caries and periodontitis can easily disrupt the oral ecological balance, leading to the risk of drug resistance. Furthermore, they are difficult to effectively break the vicious cycle of bacterial destruction and inflammatory damage, resulting in limited clinical efficacy.
A strontium-iridium titanate nanobiocatalyst (Ir-STO) was developed. This catalyst exhibits pH responsiveness, with peroxidase-like activity killing cariogenic bacteria under acidic conditions, catalase-like activity inhibiting the growth of Porphyromonas gingivalis under neutral conditions, and generating singlet oxygen under NIR light to enhance its antibacterial effect while releasing strontium ions to promote tissue repair.
Ir-STO can effectively kill cariogenic bacteria and inhibit Porphyromonas gingivalis under acidic and neutral conditions, maintain oral flora balance, reduce oxidative stress, regulate immune system balance, and promote tissue repair, providing a new approach to comprehensive treatment of periodontitis.